TGFB1 and preeclampsia: Systemic inhibition of TGF-β and VEGF, as a result of high levels of circulating placental derived soluble endoglin (sEng) and soluble fms-like tyrosine kinase 1 (sFlt1), respectively, have been reported to be involved in the pathogenesis of preeclampsia [17].